home / stock / sttk / sttk news


STTK News and Press, Shattuck Labs Inc.

Stock Information

Company Name: Shattuck Labs Inc.
Stock Symbol: STTK
Market: NASDAQ
Website: shattucklabs.com

Menu

STTK STTK Quote STTK Short STTK News STTK Articles STTK Message Board
Get STTK Alerts

News, Short Squeeze, Breakout and More Instantly...

STTK - Why Shattuck Labs Stock Soared More Than 53% Higher This Week

2026-03-06 17:02:08 ET Shattuck Labs (NASDAQ: STTK) was an outlier in the healthcare sector this week, thanks mostly to a very well-received earnings report and business update. Over the five trading days, according to data compiled by S&P Global Market Intelligence , the co...

STTK - Shattuck Labs GAAP EPS of -$0.12 beats by $0.01

2026-03-05 06:23:31 ET More on Shattuck Labs Shattuck Labs: "Hold" On Oncology Exit And Competitive TL1A/DR3 Pathway Pivot Shattuck earns new Overweight at Piper Sandler ahead of upcoming catalysts Seeking Alpha’s Quant Rating on Shattuck Labs Historic...

STTK - Shattuck Labs Reports Fourth Quarter and Full-Year 2025 Financial Results and Recent Business Highlights

Phase 1 clinical trial of SL-325 ongoing, with data expected in the second quarter of 2026 – Phase 2 clinical trial of SL-325 in patients with Crohn’s disease expected to initiate in the third quarter of 2026 – AUSTIN, Texas and DURHAM, N.C., March 05, 2026 (GLOBE NEWS...

STTK - Shattuck Labs Announces Participation in Upcoming March Investor Conferences

AUSTIN, TX and DURHAM, NC, Feb. 25, 2026 (GLOBE NEWSWIRE) -- Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK), a clinical-stage biotechnology company pioneering the development of potentially first-in-class monoclonal and bispecific DR3-blocking antibodies for the treatment of patients with inflamma...

STTK - Shattuck Labs Announces Participation in Upcoming Piper Sandler Virtual Novel Targets in Immunology Symposium

AUSTIN, TX and DURHAM, NC, Feb. 06, 2026 (GLOBE NEWSWIRE) -- Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK), a clinical-stage biotechnology company pioneering the development of novel therapeutics targeting tumor necrosis factor (TNF) superfamily receptors for the treatment of patients with inflam...

STTK - Shattuck earns new Overweight at Piper Sandler ahead of upcoming catalysts

2026-01-28 12:05:37 ET More on Shattuck Labs Shattuck Labs: "Hold" On Oncology Exit And Competitive TL1A/DR3 Pathway Pivot Seeking Alpha’s Quant Rating on Shattuck Labs Historical earnings data for Shattuck Labs Financial information for Shattuck Labs ...

STTK - Shattuck Labs: "Hold" On Oncology Exit And Competitive TL1A/DR3 Pathway Pivot

2026-01-16 13:31:18 ET The last time I spoke about Shattuck Labs ( STTK ) it was in a prior Seeking Alpha article entitled " Shattuck Labs: Positive Blood Cancer Data Leads To Mid-2024 Catalyst ". With respect to this article, I mentioned that the company had released so...

STTK - Earnings Season To Kick Off As Banking Heavyweights Report, Inflation Data In Focus

2026-01-10 11:00:00 ET Get ahead of the market by subscribing to Seeking Alpha's Wall Street Week Ahead, a preview of key events scheduled for the coming week. The newsletter keeps you informed of the biggest stories set to make headlines, including upcoming IPOs, investor days, earnings re...

STTK - Catalyst Watch: Big bank earnings, major healthcare + retail conferences, Fedspeak flurry, CPI

2026-01-09 15:00:43 ET More on the markets Don't Fight The Trump QE 2026 Forecast: Don't Fight The Fed Until It's Dead Is The Infamous 'Wall Of Worry' Finally Crumbling? AllianceBernstein sees steady growth in 2026, but flags rising volatility and policy risk...

STTK - Why Shattuck Labs Stock Soared in December

2026-01-05 22:50:09 ET A recommendation upgrade from an analyst at the beginning of December set the tone for Shattuck Labs (NASDAQ: STTK) stock in 2025's final month. The clinical-stage biotech 's share price rose by almost 74% as a result. The person responsible for that i...

Next 10